Catch up on the latest scientific research and cutting-edge Promega technologies.
Altering Genetic Destiny: The Life-Saving Power of Lynch Syndrome Detection
Lynch syndrome is the most common form of hereditary colon cancer. Explore the genetics of Lynch syndrome and learn about the importance of screening.
Living Life to the Fullest: A Decade with Lynch Syndrome
Read the story of Mike Dampf, who found out he had Lynch syndrome when he was diagnosed with colon cancer at age 37.
Dreaming of Universal Tumor Screening
Learn why cancer genetics expert Heather Hampel wants every new colorectal tumor to be tested for Lynch syndrome.
Life with Lynch Syndrome
Carrie Ketcham had her first cancer diagnosis at age 44 and was diagnosed with Lynch syndrome five year later. Read her story.
Immunogenic Cell Death: Methods to Measure Damage Associated Molecular Patterns (DAMP)
Easily monitor immunogenic cell death with two homogeneous, bioluminescent assays.
Lumit™ Cytokine Assays: Interpolating Data with the GloMax® Discover
The GloMax® Discover enables rapid interpolation of unknown cytokine concentrations.
Homogeneous Assays for Triglyceride Metabolism Research
Measuring triglycerides and their metabolism is important for understanding metabolic disease.
Verifying Cell-Based Assays for Use with 3D Models
The use of 3D models provides increased physiological relevance, but it can also present challenges.
Considerations for PCR-Based Viral Assay Development
PCR-based testing is an important tool for detecting SARS-CoV-2 virus in samples.
In the News
GEN (August 2021): New Tools Illuminate Protein-Protein Interactions
GenomeWeb (August 2021): Promega, Henlius to Develop Microsatellite Instability CDx for Cancer Drug
Precision Oncology News (July 2021): FDA Clears Promega Microsatellite Instability Test System
Labiotech.eu, (July 2021): Tracking Covid-19 Cases with Wastewater Testing
The Midwest Farm Report (July 2021): 4,800 Cars Off The Road (Promega Corporate Responsibility Report)